Recovery of Native Erythropoietin in a Patient with Erythropoietin-associated Pure Red Cell Aplasia
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
McKoy J, Stonecash R, Cournoyer D, Rossert J, Nissenson A, Raisch D
. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008; 48(8):1754-62.
PMC: 2730535.
DOI: 10.1111/j.1537-2995.2008.01749.x.
View
2.
Mattison P, Upadhyay K, Wilcox J, Moudgil A, Silverstein D
. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient. Pediatr Nephrol. 2010; 25(5):971-6.
DOI: 10.1007/s00467-009-1406-4.
View
3.
Macdougall I, Roger S, de Francisco A, Goldsmith D, Schellekens H, Ebbers H
. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int. 2012; 81(8):727-32.
DOI: 10.1038/ki.2011.500.
View